Quantcast

Latest Ciprofloxacin Stories

2008-07-18 09:00:20

By Melissa McEver, The Brownsville Herald, Texas Jul. 18--Rio Grande Valley physicians say they still plan to prescribe the antibiotic Cipro and similar drugs despite a federal government's warning that the medicines could cause tendon infections and rupture. If used properly and sparingly, Cipro and other antibiotics known as fluoroquinolones are safe for most patients, doctors said. "I'm very comfortable prescribing it," said Dr. Bruce Leibert, Harlingen family practice physician. "I...

2008-07-17 06:00:44

Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second quarter financial results for 2008 after the market closes on Thursday, July 31, 2008. The company will webcast a conference call beginning at 5:00 p.m. ET, 2:00 p.m. PT to discuss its results and to provide an update and future outlook on company events. Interested parties can access the live and archived broadcast of the call at www.depomedinc.com. About Depomed Depomed, Inc. is a specialty pharmaceutical...

a091e033a5244cdb32fa893cac699eb81
2008-07-16 15:44:34

Canadian researchers said on Tuesday that people in remote villages in South America who were treated with a common malaria drug, show high levels of resistance to a widely used class of antibiotics known as fluoroquinolones, despite never having taken the drugs. The researchers said the finding suggest that treating malaria with the cheap, widely used drug chloroquine "” a close cousin of fluoroquinolones "” may boost the risk of resistance to these antibiotics. Dr. Michael...

2008-07-15 12:00:00

After concerns were raised over severe side effects of antibiotics known as flouroquinolones, last week the Food and Drug Administration ordered manufacturers to provide additional warnings and cautionary literature for their products. The Associated Press reported the two leading drugs covered by the warning are Cipro, made by Bayer, and Levaquin, which is made by Ortho-McNeil. For everyday purposes, Cipro is often used to treat urinary tract infections, while Levaquin is generally used to...

2008-07-10 03:00:05

WASHINGTON - Drug safety officials imposed Tuesday the government's most urgent safety warning on Cipro and similar antibiotics, citing evidence that they may lead to tendon ruptures, a serious injury that can leave patients incapacitated and needing extensive surgery. The Food and Drug Administration ordered makers of flouroquinolone drugs - a potent class of antibacterials - to add a prominent "black box" warning to their products and develop new literature for patients emphasizing...

2008-07-09 09:00:00

WASHINGTON -- Drug safety officials Tuesday imposed the government's most urgent safety warning on Cipro and similar antibiotics, citing evidence that they may lead to tendon ruptures, a serious injury that can leave patients incapacitated and needing extensive surgery. The Food and Drug Administration ordered makers of fluoroquinolone drugs -- a potent class of antibacterials -- to add a prominent "black box" warning to their products and develop new literature for patients emphasizing the...

2008-07-08 15:00:56

The U.S. Food and Drug Administration says it's notified makers of fluoroquinolone antimicrobial drugs that a boxed warning is necessary for those products. The FDA said it is also requiring those manufacturers to provide a medication guide to patients about the increased risk of tendinitis and tendon rupture. Fluoroquinolones are effective in treating certain bacterial infections but healthcare professionals and patients need to be aware of the increased risk associated with the use of...

2008-07-03 09:01:19

FDC has received approval from the FDA for its abbreviated new drug application, Ciprofloxacin ophthalmic solution. FDC's Ciprofloxacin Ophthalmic Solution is a broad spectrum antibiotic used for occular surface infections. The company has recently received approval for Timolol maleate ophthalmic solution. Another abbreviated new drug application Ofloxacin ophthalmic solution is in the final stages of approval.

2008-07-01 09:01:11

Aradigm has announced positive results from an open-label, two week efficacy and safety study of its once daily inhaled liposomal ciprofloxacin in patients with cystic fibrosis. The primary efficacy endpoint in this Phase II study was the change from baseline in the sputum Pseudomonas Aeruginosa colony forming units (CFU), an objective measure of the reduction in pulmonary bacterial load. Data analysis in 21 patients who completed the study, demonstrated that the Pseudomonas CFU decreased...

2008-06-30 09:02:20

Aradigm Corporation (OTCBB:ARDM) (the "Company") today announced positive results from an open-label, two week efficacy and safety study of its once daily inhaled liposomal ciprofloxacin in patients with cystic fibrosis (CF). The study conducted at leading CF centers in Australia and New Zealand enrolled a total of 22 patients. The primary efficacy endpoint in this Phase 2 study was the change from baseline in the sputum Pseudomonas Aeruginosa colony forming units (CFU), an objective...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related